Common Shares in Issue and Total Voting Rights

By

Regulatory News | 03 Jun, 2019

Updated : 07:05

RNS Number : 8458A
PetroTal Corp.
03 June 2019
 

 

3 June 2019

PetroTal Corp.

 

Common Shares in Issue and Total Voting Rights

 

 

PetroTal Corp. ("PetroTal" or the "Company") (TSX-V: TAL and AIM: PTAL), an independent oil and gas company with assets and operations in Peru, announces that further to the Company's announcement on 31 May 2019, the Company confirms that following the issue of the Placing Shares (as defined in the 31 May 2019 announcement), the Company will have 671,074,324 Common Shares in issue and there are no shares held in treasury. 


For the purposes of the Disclosure Guidance and Transparency Rules,
the total number of voting rights in the Company is calculated as the number of outstanding Common Shares, less the Common Shares not able to be voted on due to restrictions applicable to certain holders which results in a total voting rights figure of 626,296,621. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

ENDS

 

 

CONTACT DETAILS:


PetroTal Corp.

Manuel (Manolo) Pablo Zúñiga-Pflücker (President and CEO)

Greg Smith (EVP and CFO)

 Tel: +1 713 609 9101





Strand Hanson Limited

(Nominated & Financial Adviser)

James Spinney / Ritchie Balmer / Eric Allan

Tel: +44 (0) 20 7409 3494





GMP FirstEnergy

(Joint Broker)

Jonathan Wright / Hugh Sanderson

 Tel: +44 (0) 20 7448 0200

 





Numis Securities Limited

(Joint Broker)

John Prior / Emily Morris

Tel: +44 (0) 20 7260 1000

 





Celicourt Communications

(Financial PR)

Mark Antelme / Jimmy Lea

 Tel: +44 (0) 20 7520 9261

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFTMJTMBIMBFL

Last news